mirna-506-3p directly regulates rs10754339 (a/g) in immune checkpoint protein b7-h4 in breast cancer
Published 3 years ago • 87 plays • Length 4:48Download video MP4
Download video MP3
Similar videos
-
1:14
phase i study of abbv-383, a bcma×cd3 bispecific antibody, in r/r myeloma
-
3:34
exciting results for bcma/cd3 bispecific elranatamab (pf-3135) in r/r mm
-
6:30
(part 3/3) health and medicines policies in the scottish national health system
-
1:29
bispecific bcma-cd3 antibody teclistamab is efficacious and tolerable in r/r mm
-
3:23
intravesical chemotherapy and chemohypherthermia in non-muscle-invasive bladder cancer
-
1:03:39
deep insight into immuno-oncology: immunotherapy pathways, targets, and biomarkers
-
3:13
nuclear targeting of gold nanoparticles for improved therapeutics
-
36:30
transcreener cd73 assay leveraging nucleotide detection to measure adenosine
-
2:24
treating viral-induced malignancies and covid-19 using a cd73 inhibitor
-
2:37
exploratory analysis of frontline therapies in revel: phase 3 trial of ramucirumab in nsclc
-
4:23
keynote-407: 3-year follow-up of pembrolizumab plus chemo in nsclc
-
1:26
nanochembio: development of therapeutic and diagnosis strategies
-
20:09
apcca2019_033_session 6: drugs and targets in development
-
43:42
7 panel3 part1
-
1:35
3rd wcticim 2025 rio de janeiro, brazil
-
1:18:48
webinar: treatment as prevention (feb 8 2013)
-
5:32
lymphoma guidelines in venezuela
-
48:54
keynote: accelerating the discovery of next-generation medicines for human disease
-
1:22
too many medications | your kidneys your health
-
10:51
raúl insa (som biotech): repurposing drugs in neurodegenerative disorders
-
2:14
what are the potential immune-related toxicities to be mindful of when prescribing nivo and pembro?
-
1:09:28
special lecture: manuel serrano, phd - tumor suppressor genes in cancer and beyond